Regulators on Thursday said they won't speed up the review of manufacturing changes required for Boston Scientific Corp. to resume selling its implantable heart defibrillators. The medical-device maker recalled all seven brands of its defibrillators...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Heart Device Won't Get Quick Review
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account